Related references
Note: Only part of the references are listed.In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
Abdullah Ely et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Enhanced integrin affinity and neural differentiation of induced pluripotent stem cells using Ln5-P4-grafted amphiphilic solid lipid nanoparticles
Yung-Chih Kuo et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Advances in lipid carriers for drug delivery to the gastrointestinal tract
Yining Xu et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2021)
Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo
Mahmoud A. Younis et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery
Yuchen Fan et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Sarah Kadelka et al.
SCIENTIFIC REPORTS (2021)
The find of COVID-19 vaccine: Challenges and opportunities
Marwan ElBagoury et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Nanomedicines: Redefining traditional medicine
Weijia Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses
Giulia Anderluzzi et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Invasomes: Potential vesicular systems for transdermal delivery of drug molecules
Shweta Jain et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Srinivasa Reddy Bonam et al.
NANO TODAY (2021)
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity
Mai N. Vu et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Solid lipid nanoparticles for oral drug delivery
S. Khaleel Basha et al.
MATERIALS TODAY-PROCEEDINGS (2021)
Perspectives on the Future of Nanomedicine to Impact Patients: An Analysis of US Federal Funding and Interventional Clinical Trials
Anthony J. McGoron
BIOCONJUGATE CHEMISTRY (2020)
Trends in Therapeutic Conjugates: Bench to Clinic
Arnab Rudra et al.
BIOCONJUGATE CHEMISTRY (2020)
Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery
Samira Nasirizadeh et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2020)
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
Nuphar Veiga et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Current status of potential therapeutic candidates for the COVID-19 crisis
Jiancheng Zhang et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery
Yusuke Hirai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
Manish R. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Niosomes: A review on niosomal research in the last decade
Peeyush Bhardwaj et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
Eric M. Mucker et al.
SCIENTIFIC REPORTS (2020)
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
Hsin- Shih et al.
BIOMEDICAL JOURNAL (2020)
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan et al.
ACS NANO (2020)
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Carsten Weiss et al.
ACS NANO (2020)
Liposomes: Advancements and innovation in the manufacturing process
Sanket Shah et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
Takashi Nakamura et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Eleni Samaridou et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Lipid-based nanoparticle technologies for liver targeting
Roland Boettger et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Sei Yonezawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Emerging vaccine delivery systems for COVID-19 Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine
Nigel Theobald
DRUG DISCOVERY TODAY (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses
Seiki Shirai et al.
VACCINES (2020)
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
Marion M. Deken et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Jing Lu et al.
CELL RESEARCH (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Vaccines for COVID-19: The current state of play
Archana Koirala et al.
PAEDIATRIC RESPIRATORY REVIEWS (2020)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network
Mai N. Vu et al.
SMALL (2020)
COVID-19 Vaccine: A comprehensive status report
Simran Preet Kaur et al.
VIRUS RESEARCH (2020)
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Paul F. McKay et al.
NATURE COMMUNICATIONS (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
Gustavo Lou et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Delivering the power of nanomedicine to patients today
Matthieu Germain et al.
JOURNAL OF CONTROLLED RELEASE (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery
Shakthi Apsara Thejani Opatha et al.
PHARMACEUTICS (2020)
Solid lipid nanoparticles for enhanced oral absorption: A review
Eman Salah et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles
Danijela Zukancic et al.
PHARMACEUTICS (2020)
Advances in drug delivery systems: Work in progress still needed?
Flavia Laffleur et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications
Indhu A. Chacko et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods
Tatiana Mashel et al.
BIOMATERIALS (2020)
Therapeutic siRNA: state of the art
Bo Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The continued advance of vaccine adjuvants - 'we can work it out'
Derek T. O'Hagan et al.
SEMINARS IN IMMUNOLOGY (2020)
Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives
Yang Shi
ADVANCED THERAPEUTICS (2020)
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Yongtao Duan et al.
RSC ADVANCES (2020)
Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy
Kyuri Lee et al.
BIOMATERIALS SCIENCE (2020)
Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo
Yaohua Wei et al.
ACTA BIOMATERIALIA (2019)
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shuting Shi et al.
VACCINE (2019)
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
Kimberly J. Hassett et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Peptide-guided nanoparticles for glioblastoma targeting
Pille Saalik et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target
Nuphar Veiga et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery
Yingli Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
Imane El Dika et al.
ONCOLOGIST (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function
M. Ramezanpour et al.
NANOSCALE (2019)
On the role of helper lipids in lipid nanoparticle formulations of siRNA
Jayesh A. Kulkarni et al.
NANOSCALE (2019)
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
Jayesh A. Kulkarni et al.
ACS NANO (2018)
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation
Jerome Widmer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
Staci Sabnis et al.
MOLECULAR THERAPY (2018)
Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery
Narottam Lamichhane et al.
MOLECULES (2018)
A modular platform for targeted RNAi therapeutics
Ranit Kedmi et al.
NATURE NANOTECHNOLOGY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Jayesh A. Kulkarni et al.
NUCLEIC ACID THERAPEUTICS (2018)
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster et al.
BRITISH JOURNAL OF CANCER (2018)
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Nuphar Veiga et al.
NATURE COMMUNICATIONS (2018)
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
Christos Tapeinos et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles
Hedi Hunt et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
Michael J. Wagner et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
Srinivasa Reddy Bonam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
A. Cervantes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
Yang Wu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles
Lin Wei et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA
Haitang Wang et al.
MOLECULAR THERAPY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Abstracts Presented at the 8th Annual Meeting of the North American NeuroEndocrine Tumor Society, October 14–18, 2015, Austin, Texas
PANCREAS (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens
Gokul Swaminathan et al.
VACCINE (2016)
A phase I/II study of TKM-080301, a PLK1-targeted RNAi in patients with adrenocortical cancer (ACC).
Michael J. Demeure et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
mRNA vaccine delivery using lipid nanoparticles
Andreas M. Reichmuth et al.
THERAPEUTIC DELIVERY (2016)
Preclinical and clinical development of siRNA-based therapeutics
Gulnihal Ozcan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Human placental cell and tissue uptake of doxorubicin and its liposomal formulations
Suvi K. Soininen et al.
TOXICOLOGY LETTERS (2015)
Lipid-based mRNA vaccine delivery systems
Patrick Midoux et al.
EXPERT REVIEW OF VACCINES (2015)
The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations
Zixiu Du et al.
SCIENTIFIC REPORTS (2014)
Development of liposomal formulations: From concept to clinical investigations
Yuchen Fan et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
Huali Wu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo
Yusuke Sato et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3 beta[N ',N '-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses
Malou Henriksen-Lacey et al.
MOLECULAR PHARMACEUTICS (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation
Hidetaka Akita et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
S. C. White et al.
BRITISH JOURNAL OF CANCER (2006)
The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes
SM Moghimi
BIOMATERIALS (2006)
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
ES Kim et al.
LUNG CANCER (2001)
Share Paper
